Delirium Epidemiology Forecast 2026-2035

Read more about this report - Request a Free Sample

Delirium Epidemiology Forecast Report Coverage

Expert Market Research's “Delirium Epidemiology Forecast Report 2026-2035” offers comprehensive information on the prevalence and demographics of delirium. It projects the future incidence and prevalence rates of delirium cases across various populations. The study covers age, gender, and type as major determinants of the delirium population. The report highlights patterns in the prevalence of delirium over time and projects future trends based on multiple variables.

Delirium Understanding: Disease Overview

Delirium is an acute neuropsychiatric syndrome characterized by a sudden onset of fluctuating disturbances in attention, awareness, and cognition. It commonly occurs in hospitalized and critically ill patients, particularly older adults, and is often triggered by underlying medical conditions, infections, surgery, or medication effects. Clinically, delirium presents in hyperactive, hypoactive, or mixed subtypes, with hypoactive forms frequently underdiagnosed. The condition is associated with increased morbidity, prolonged hospital stays, and higher mortality rates. Its multifactorial etiology and reversible nature make early recognition and prompt management essential to improving patient outcomes and reducing healthcare burden.

Delirium Epidemiology Perspective

The delirium epidemiology division offers information on the patient pool from history to the present, as well as the projected trend for each of the 8 major markets. Expert Market Research provides both current and predicted trends for the delirium epidemiology scenario by examining a wide range of studies. Additionally, the report covers the diagnosed patient pool for delirium and their trends. The delirium detailed epidemiology segmentation is broken down into specific categories, such as total prevalent cases in males and females, and total diagnosed cases across different age groups and patient pools.

• According to Amanda Y Leong, et al., 2025,a meta-analysis of over 180,000 ICU patients reported a pooled delirium prevalence of 35.7% and incidence of 28.8%, confirming a substantial global burden in critical care settings.
• As per Selin Erel et al., 2024, the delirium has incidence of 32.5%, with higher rates observed among critically ill patients and those with factors such as mechanical ventilation and organ dysfunction.
• According to Faisal, Hina, et al., 2024 delirium has a prevalence of ~47.7% among post-surgical ICU patients, with higher occurrence in older individuals and those with comorbidities or ventilation support.
• Rajaa Saleh Al Farsi, et al., 2023, clinical study show delirium disproportionately affects adults aged ≥65 years, with prevalence reaching 50% in hospitalized elderly populations, highlighting aging as the strongest independent risk factor.

Read more about this report - Request a Free Sample

Country-wise Delirium Epidemiology Segment

The delirium epidemiology data and findings for the United States, Germany, Spain, Italy, France, the United Kingdom, Japan, and India are also provided in the epidemiology section.

Delirium remains a significant clinical burden in both the United States and the United Kingdom, particularly among hospitalized and elderly populations. As per Heidi Lindroth, et al., 2024, in the United States, delirium prevalence ranges from approximately 16% to 18% among hospitalized patients, with rates rising to nearly 23.6% in older adults. Similarly, according to British Geriatrics Society, United Kingdom data suggest a prevalence of around 14%-15% in general hospital settings, with a higher incidence observed in acute and emergency care environments. Across both countries, advancing age, frailty, and comorbidities remain the strongest risk factors driving delirium occurrence and associated adverse outcomes.

Delirium: Treatment Overview

The management of delirium primarily focuses on identifying and addressing underlying causes while implementing supportive care strategies. Non-pharmacological interventions, including orientation protocols, sleep optimization, early mobilization, and hydration, form the cornerstone of treatment. Pharmacological therapy is reserved for severe agitation or distress, with low-dose antipsychotics such as Haloperidol commonly used, although evidence remains variable. Avoidance of high-risk medications, particularly sedatives and anticholinergics, is critical. In intensive care settings, multicomponent care bundles are increasingly adopted to prevent and manage delirium, reflecting a shift toward holistic, patient-centered approaches aimed at reducing complications and improving recovery outcomes.

Key Questions Answered

• What are the key findings of delirium epidemiology in the 8 major markets?
• What will be the total number of patients with delirium across the 8 major markets during the forecast period?
• What was the country-wise delirium epidemiology scenario in the 8 major markets in the historical period?
• Which country will have the highest number of cases of delirium during the forecast period of 2026-2035?
• Which key factors would influence the shift in the patient population of delirium during the forecast period of 2026-2035?
• What are the currently available treatments for delirium?
• What are the disease risks, signs, symptoms, and unmet needs of delirium?

Scope of the Delirium Epidemiology Report

• The report covers a detailed analysis of signs and symptoms, causes, risk factors, pathophysiology, diagnosis, treatment options, and classification/types of delirium based on several factors.
• Delirium Epidemiology Forecast Report covers data for the eight major markets (the US, France, Germany, Italy, Spain, the UK, Japan, and India).
• The delirium report helps to identify the patient population, and the unmet needs are highlighted along with an assessment of the disease's risk and burden.

Related Reports

Mild Cognitive Impairment (MCI) Market

Mild Cognitive Impairment Drug Pipeline Analysis Report